Prostate cancer trials in United States

In United States 655 Also abroad 1490

655 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in United States
Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate Cancer
Where
Atlanta
Age
18 years and over
People
88
Run by
Emory University
See details and how to joinNCT07860554
No phaseTaking people
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Where
Brooklyn, Jamaica, New York, Richmond Hill
Age
18 years and over
People
445
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04751435
Phase 1/2Taking people
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Where
Boston, Chicago, Houston, La Jolla, Los Angeles, New York, Portland, Richmond, San Antonio, San Francisco
Age
18 years to 130 years
People
695 worldwide
Run by
AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00
Phase 2Taking people
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
Where
Duarte, Los Angeles, Salt Lake City
Age
18 years and over
People
116
Run by
Edwin Posadas, MD
See details and how to joinNCT05534646
No phaseTaking people
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
Where
Carmel, Indianapolis
Age
40 years and over
People
100
Run by
Indiana University
See details and how to joinNCT05879913
No phaseTaking people
A Study of Mental Health Care in People With Cancer
Where
New York
Age
65 years and over
People
130
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06037954
Phase 1Taking people
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Where
Aurora, Boston, Columbus, Gilbert, Grand Rapids, Nashville, New Orleans, New York, San Antonio, Sarasota, West Valley City
Age
18 years and over
People
180 worldwide
Run by
Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193
Phase 1/2Taking people
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Where
Denver, East Brunswick, Nashville, New Haven, Phoenix, Rochester
Age
18 years and over
People
85 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06990880 · EU 2025-521581-10-00
Phase 2Taking people
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Where
Los Angeles
Age
45 years and over
People
80
Run by
Cedars-Sinai Medical Center
See details and how to joinNCT07223385
Phase 1/2Taking people
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Where
Austin, Bedford, Boston, Charleston, Cleveland, Dallas, Denver, Detroit, Durham, Fairfax, Houston, Irvine, La Jolla, Los Angeles, Madison, Miami, Nashville, Newark, New Haven, New York, Oklahoma City, Orlando, Philadelphia, Pittsburgh, Port Charlotte, Portland, San Antonio, Seattle, York
Age
12 years and over
People
300 worldwide
Run by
PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750
Phase 2Taking people
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
Where
Boston, Cleveland, Durham, New York, Omaha, San Diego, St Louis
Age
18 years and over
People
93
Run by
Convergent Therapeutics
See details and how to joinNCT06549465
Phase 3Taking people
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
Where
Jacksonville, Scottsdale
Age
18 years and over
People
108
Run by
Mayo Clinic
See details and how to joinNCT06625034
Phase 2Taking people
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Where
Cleveland
Age
19 years and over
People
44
Run by
Case Comprehensive Cancer Center
See details and how to joinNCT06738303
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Austin, Baltimore, Boston, Celebration, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Durham, East Brunswick, Gainesville, Hackensack, Hershey, Indianapolis, Irving, Jacksonville, Las Vegas, Littleton, Louisville, Miami, Milwaukee, Myrtle Beach, Nashville, Newark, New Haven, New York, Omaha, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Plano, Plantation, Portland, Rochester, Santa Barbara, Syracuse, Tampa, Tucson, Tyler
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
No phaseTaking people
PET/CT Characterization of Treatment Resistance
Where
Madison
Age
18 years and over
People
25
Run by
University of Wisconsin, Madison
See details and how to joinNCT05647564
Phase 1/2Taking people
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Where
Dothan, Grand Rapids, Houston, Omaha
Age
18 years and over
People
61
Run by
Radiopharm Theranostics, Ltd
See details and how to joinNCT07189871
No phaseNot yet taking people in United States
Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
Where
Houston
Age
18 years to 100 years
People
94
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT07852949
No phaseTaking people
Addressing Health Literacy With a Tailored Survivorship Care Plan
Where
Atlanta
Age
18 years and over
People
150
Run by
Emory University
See details and how to joinNCT06674863
Phase 2Taking people
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Where
Jacksonville
Age
18 years and over
People
27
Run by
Mayo Clinic
See details and how to joinNCT07285044
Phase 3Taking people
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Where
Hampton, Oklahoma City, Scottsdale, Warrenville
Age
18 years and over
People
192
Run by
Proton Collaborative Group
See details and how to joinNCT01492972
No phaseTaking people
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.
Where
Syosset
Age
50 years to 99 years
People
20
Run by
Northwell Health
See details and how to joinNCT05148156
No phaseTaking people
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
Where
Jacksonville
Age
21 years to 80 years
People
250
Run by
Mayo Clinic
See details and how to joinNCT06541210
Phase 2Taking people
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
Where
Los Angeles
Age
18 years to 90 years
People
81
Run by
Jonsson Comprehensive Cancer Center
See details and how to joinNCT07185165
No phaseTaking people
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Where
Augusta, Austin, Boca Raton, Boston, Chandler, Cleveland, Clifton, Houston, Philadelphia, Richmond, Santa Barbara
Age
18 years and over
People
84 worldwide
Run by
Palette Life Sciences, Inc.
See details and how to joinNCT06496256
No phaseTaking people
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Where
Bowling Green, Hanover, Meridian, Middletown, Myrtle Beach, San Diego, Towson
Age
40 years to 75 years
People
500
Run by
Sequenom, Inc.
See details and how to joinNCT07543757